New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → whytestocks Sep 11, 2019 at 1:30 PM 128 $OMER News Article - FDA Confirms Omeros' Schedule for Rolling Review of the Company's BLA for Narsoplimab in the Treatment of HSCT-TMA https://marketwirenews.com/news-releases/fda-...44524.html My Twitter: WhyteStocks Newer Older